Effect of human leukocyte A interferon on prevention of infectious bovine rhinotracheitis virus infection of cattle.
Human leukocyte A interferon was evaluated for its ability to prevent infectious bovine rhinotracheitis virus-induced respiratory tract disease in cattle. Weanling calves were treated daily for 1 week with 50 X 10(6) U of interferon, intranasally (by nebulization) and IM, and inoculated with infectious bovine rhinotracheitis virus on the first day of treatment. Respiratory tract disease was less severe in treated as compared with nontreated calves which were given only infectious bovine rhinotracheitis virus, and infection in the treated calves occurred later than in the untreated calves. Viral shedding and appearance of viral neutralizing antibodies occurred later in treated calves than in calves given only virus. Because several calves in a treatment group were housed together, whether the late appearance of infection in some interferon-treated calves was due to emergence of suppressed virus or to horizontal transmission from calves shedding virus could not be determined. One calf in the interferon-treated group developed antibody to human interferon and a few treated calves had transient elevation of hepatic enzymes. Interferon-treated calves developed a high temperature which subsided on termination of treatment. Production of disease was considerably dependent on the amount of virus and interferon given, since calves given 300 times more virus and approximately half as much interferon showed no evidence of protection against infection.
Roney
C S
CS
Rossi
C R
CR
Smith
P C
PC
Lauerman
L C
LC
Spano
J S
JS
Hanrahan
L A
LA
William
J C
JC
D000281:Administration, Intranasal; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D002417:Cattle; D004305:Dose-Response Relationship, Drug; D007242:Herpesvirus 1, Bovine / Q000276:immunology; D006801:Humans; D007241:Infectious Bovine Rhinotracheitis / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D007273:Injections, Intramuscular / Q000662:veterinary; D007370:Interferon Type I / Q000008:administration & dosage / Q000627:therapeutic use*; D009500:Neutralization Tests; D012137:Respiratory System / Q000473:pathology
D000914:Antibodies, Viral; D007370:Interferon Type I